A 2A adenosine receptors are expressed on immune cells including neutrophils, lymphocytes, eosinophils, monocytes/macrophages, and mast cells. Activation of A 2A receptors on these cells stimulates an increase in [cyclic AMP] i and causes a diminution of inflammatory responses. In mast cells, degran
Adenosine A2A receptors of human circulating blood elements
β Scribed by Katia Varani; Stefania Gessi; Stefania Merighi; Ennio Ongini; Pier Andrea Borea
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 119 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
Recent studies have clearly shown that the adenosine A 2A receptors are present in a variety of peripheral tissues, including smooth muscle cells, heart muscle and coronary arteries, and human circulating blood elements. This paper reviews the studies performed by our research group on the A 2A receptors on human platelets, lymphocytes, and neutrophils. Affinity and potency of typical adenosine receptor ligands were compared in binding and functional studies as adenylyl cyclase, aggregation, and superoxide anion production assays. Saturation experiments, performed by using the selective A 2A adenosine receptor antagonist
] pyrimidine) revealed a single class of binding sites in all different preparations examined with affinity values in the nanomolar range (0.85-1.34 nM) and Bmax values ranging from 35 to 80 fmol/mg protein. Competition experiments showed that the potency order of agonists and antagonists studied was similar in all human circulating blood elements. In the functional assays, the same compounds exhibited a rank order of potency identical to that observed in binding experiments. Moreover, an excellent rank order correlation was found between cAMP accumulation, aggregation, and superoxide anion production data by adenosine receptor agonists and antagonists examined. Thermodynamic data indicated that [ 3 H]SCH 58261 binding to human lymphocytes and neutrophils is entropy and enthalpy driven, a finding in agreement with the thermodynamic behaviour of antagonists binding to rat striatal A 2A adenosine receptors.
π SIMILAR VOLUMES
Partial agonists and antagonists were synthesized and evaluated biologically for extended pharmacologic characterization of the human adenosine A 3 receptor. The affinities of all compounds were determined at the human adenosine A 3 receptor stably transfected in HEK 293 cells and in rat brain membr
A series of novel and known 5-substituted 7-amino-2-(2-furyl) [1,2,4]triazolo [1,5a][1,3,5]triazine derivatives were synthesized and tested for adenosine receptor antagonism in radioligand binding assays at all four adenosine receptor subtypes and for inhibition of the agonist-induced cyclic AMP res
The four adenosine receptor subtypes have been stably transfected into Chinese hamster ovary (CHO) cells allowing for comparative studies in a similar cellular background, using radioligand binding studies (A 1 , A 2A , A 3 ) or adenylyl cyclase activity assays (A 2B ). We are currently using the tr
## 2-[(cyclohexylmethylene)hydrazino]adenosine (MRE-0470 ) is an A 2A -adenosine receptor agonist that is a potent and selective coronary vasodilator. As part of a preclinical program, the pharmacology and toxicology of MRE-0470 have been studied in the rat. In isolated vas deferens, MRE-0470 act